Nifedipine and beta blockers: a potentially dangerous association?
Motté, G.; Chanu, B.; Sébag, C.; Bénaim, P.
La Nouvelle Presse Medicale 9(6): 379-380
1980
ISSN/ISBN: 0301-1518 PMID: 7383907 Document Number: 166104
Document emailed within 1 workday
Related Documents
Cizmáriková, R.; Valentová, J.; Hutt, A.J.; Sedláková, S. 2005: Blockers of beta-adrenergic receptors--a group of chiral agents stereoselective synthesis of beta-blockers Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 54(5): 201-206Albanese, C.; Di Mario, F. 1983: Therapeutic association in chronic stable angina: verapamil plus beta-blockers Recenti Progressi in Medicina 74(4): 517-519
Tavazzi, L. 1999: Practical advice on the treatment of cardiac insufficiency with beta-blockers. Announcement by the Italian Association of Hospital-based Cardiologists Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 18(5): 556-557
Kozlov, S.S.; Turitsin, V.S.; Gavrilyuk, T.V. 2015: Common rat endoparasites potentially dangerous to humans Meditsinskaia Parazitologiia i Parazitarnye Bolezni 3: 48-52
Held, P.H.; Yusuf, S. 1993: Effects of beta-blockers and calcium channel blockers in acute myocardial infarction European Heart Journal 14(Suppl): 18-25
Chourashy, B.K. 1988: Anti-anginal drugs: calcium channel blockers, beta-adrenergic blockers and nitrates Journal of the Indian Medical Association 86(10): 274-276
Coutts, L.C. 1997: Alpha blockers, diuretics and beta blockers for hypertension American Family Physician 55(7): 2431
Nakamura, T.; Hosohata, Y.; Hosohata, K.; Hattori, K.; Suzuki, J.; Nagatomo, T. 1999: Relationship between hydrophobicity and beta-blocking potencies, affinities or dissociation of beta-blockers from beta-adrenoceptors Research Communications in Molecular Pathology and Pharmacology 106(3): 203-211
Tartakovskiĭ, I.S.; Gintsburg, A.L.; Demina, I.V.; Gruzdeva, O.A. 2010: Methodic bases for providing the population and potentially dangerous water objects with biosafety against the pathogens of Legionellosis Gigiena i Sanitariia 5: 82-85
Pala, A.M.; Ricciardelli, D.; Sanna, A.; Vinattieri, M.A. 1989: The effect of beta blockers on the QT interval: the possible role of mechanisms other than beta block Minerva Medica 80(12): 1283-1287
Paraskos, J.A. 1986: Cardiovascular pharmacology. III: Atropine, calcium, calcium blockers, and beta-blockers Circulation 74(6 Part 2): Iv86-Iv89
Verbeuren, T.J.; Zonnekeyn, L.L.; Prost, J.F.; Herman, A.G. 1989: Prejunctional beta-adrenoceptors in the isolated perfused rat kidney: a comparative study of the beta-blockers tertatolol and propranolol Archives Internationales de Pharmacodynamie et de Therapie 298: 183-197
Schulte, K.L.; Laber, E.; Meyer-Sabellek, W.A.; Distler, A.; Gotzen, R. 1985: Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 3(3): S239-S241
Vestbo, J.; Lange, P. 1994: Beta 2 agonists: were they nevertheless not dangerous? Ugeskrift for Laeger 156(40): 5882-5883
Garewal, H.; Durie, B.G. 1981: Beta 2-microglobulin: a potentially useful marker for hematologic malignancies Arizona Medicine 38(12): 912-913
Kirby, B.J.; Kitchin, N.R. 1999: A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension International Journal of Clinical Practice 53(5): 339-343
Clemens, W.J. 1981: Beta-blockers: how different are they really? Zfa. Zeitschrift für Allgemeinmedizin 57(11): 869-871
Flammer, J. 1984: The use and hazards of beta blockers Therapeutische Umschau. Revue Therapeutique 41(4): 251-254
Zacharias, F.J. 1973: Beta blockers in hypertension Bruxelles Medical Spec No : 111-146
Nieminen, M.S.; Partanen, J. 1992: Beta blockers today Nordisk Medicin 107(5): 150-152; 156